Blueprint Medicines Corporation
Cambridge, MA
- UEI
- W42KVS8X5BV9
- CAGE
- 6NX60
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 45 Sidney St, Cambridge, MA 02139, USA
- Website
- blueprintmedicines.com
- Founded
- 2011
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Ayvakit (AVAPRITINIB) | Veterans Integrated Service Network 20 (VHA) | $0 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Incyte Corporation | Wilmington, DE | 325412 Pharmaceutical Preparation Manufacturing |
| Fennec Pharmaceuticals, Inc. | Durham, NC | 325412 Pharmaceutical Preparation Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Phathom Pharmaceuticals, Inc. | Florham Park, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Servier Pharmaceuticals LLC | Boston, MA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Blueprint Medicines Corporation, doing business as Blueprint Medicines, is a corporate entity registered in SAM.gov as a for-profit manufacturer of goods. As a pharmaceutical company, Blueprint Medicines provides various drug products to federal agencies through contract awards.
Through prime federal contracts, Blueprint Medicines has delivered the drug AYVAKIT (AVAPRITINIB) to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network facilities. These firm fixed price delivery orders support the VA's healthcare programs and were awarded against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract held by Blueprint Medicines as a large business prime contractor. No set-aside designations were applied to these awards made by the VA to Blueprint Medicines for the provision of pharmaceutical products.
Blueprint Medicines holds multiple Federal Supply Schedule (FSS) contract IDVs under the Pharmaceuticals and Drugs schedule for providing a range of drug and hematology-related products to federal agencies like the VA. One FSS IDV awarded by the VA Veterans Integrated Service Network 20 has a potential value of $3,000,000 and ordering period through July 31, 2025, allowing the VA to place task orders with Blueprint Medicines for pharmaceutical goods. Another FSS interim agreement awarded by the VA Veterans Integrated Service Network 12 had a smaller potential value of $25,000 for procuring drug products from Blueprint Medicines. As the prime contractor under these multi-award FSS vehicles, Blueprint Medicines can receive orders from federal agencies for pharmaceuticals and related hematology items.
Quick answers
Is Blueprint Medicines Corporation registered in SAM.gov?
Yes. Blueprint Medicines Corporation's SAM.gov registration is active through October 27, 2027.
What is Blueprint Medicines Corporation's CAGE code?
Blueprint Medicines Corporation's CAGE code is 6NX60, and its Unique Entity ID (UEI) is W42KVS8X5BV9.
Which contract vehicles does Blueprint Medicines Corporation hold?
Blueprint Medicines Corporation holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Blueprint Medicines Corporation's most recent federal award?
Blueprint Medicines Corporation's most recent federal contract award is Ayvakit (AVAPRITINIB) (36C26021F0017), from Veterans Integrated Service Network 20 (VHA), on October 1, 2020.
On GovTribe
See Blueprint Medicines Corporation's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors